ADC Therapeutics SA ADCT 深 沪
已收盘 12-19 16:00:00 美东时间
3.73
-0.170
-4.36%
华盛通- 最 高4.05
- 今 开4.00
- 成交量 318.71万股
- 最 低 3.72
- 昨 收 3.90
- 总市值 4.18亿
- 52周最高 4.80
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.05
- 委 比 -14.29%
- 总股本 1.12亿
- 历史最高 56.59
- 量 比 1.82
- 振 幅 8.46%
- 历史最低 0.3599
- 每 手 1
- 风险率 1.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /PRNewswire/ -- Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has...
12-19 20:55
Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around...
12-04 21:00
Why Is ADC Therapeutics Plunging Today
Zynlonta and glofitamab show high response and durable remission rates in early r/r DLBCL trial data from ADC Therapeutics, with enrollment ongoing into 2026.
12-04 03:40
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial
Company to host corporate webcast to share updated data on December 3, 2025 LAUSANNE, Switzerland, Dec. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global le...
12-03 05:05
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Dec. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
12-02 05:05
ADC Therapeutics Q3 Adj. EPS $(0.19) Beats $(0.36) Estimate, Sales $16.427M Miss $17.077M Estimate
ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.36) by 47.51 percent. This is a 32.14 percent increase over losses of $(0.28) per share from
11-10 20:32
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Earnings Preview For ADC Therapeutics
ADC Therapeutics (NYSE:ADCT) is gearing up to announce its quarterly earnings o...
11-08 01:04
ADC Therapeutics to Present at November Investor Conferences
LAUSANNE, Switzerland, Oct. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ann...
10-27 19:15
美股大行评级 | Needham上调台积电目标价升至360美元！美国银行、摩根士丹利分别获多家机构上调目标价
今日重点评级关注：Rosenblatt：维持HIVE Digital Technologies"买入"评级，目标价从5美元升至10美元；摩根大通：维持Array Technologies"超配"评级，目标价从13美元升至15美元
10-17 09:58
